SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Revenue History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹48,497 Cr | ₹43,886 Cr | ₹38,654 Cr | ₹33,498 Cr | ₹32,838 Cr |
What is the latest Revenue of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Revenue |
---|---|
Mar2025 | ₹48,497 Cr |
Mar2024 | ₹43,886 Cr |
Mar2023 | ₹38,654 Cr |
Mar2022 | ₹33,498 Cr |
Mar2021 | ₹32,838 Cr |
How is Revenue of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹48,497 Cr | 10.51 | |
Mar2024 | ₹43,886 Cr | 13.53 | |
Mar2023 | ₹38,654 Cr | 15.39 | |
Mar2022 | ₹33,498 Cr | 2.01 | |
Mar2021 | ₹32,838 Cr | - |
Compare Revenue of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹397,336.1 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics | |
MANKIND PHARMA | ₹109,835.0 Cr | 3% | 6.2% | 7.5% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | 3.4% |
1.3% |
-11.6% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses